Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hochman David P, holds the title of See Remarks at Orchestra BioMed Holdings, Inc..
On 2026-09-10, the insider transacted 6,566 shares.The shares were transacted at a weighted average price of $5.81 per share, resulting in a total market-relevant value of $38K.
Hochman David P (See Remarks) had withheld for taxes $38K of $OBIO
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.